AI & MACHINE LEARNING FOR CLINICAL TRIAL AND R&D ADVANCEMENTS, PHILADELPHIA, JUNE 14-15, 2018
Artificial intelligence is now recognized as a powerful tool for enhancing research and development operations. Innovations in machine learning have the ability to analyze large volumes of data for better insights into diseases and drug development. While applications, systems, and platforms have been developed to transform clinical trial innovation, there has not been a standard for benchmarking in AI’s actual execution.
At the AI & Machine Learning for Clinical Trial and R&D Advancements event, our high-caliber speaking faculty of machine learning and drug development leaders provides key insights into the AI vertical use in clinical trials. Attendees will walk away with the ability to successfully implement AI platforms to advance drug discovery, streamline clinical trials, and coordinate site-sponsor activities.
Who Should Attend
This conference is designed for professionals from pharmaceutical, biotechnology and medical device companies with responsibilities in:
Top Five Reasons to Attend